|
Market Closed -
Hong Kong S.E.
04:08:09 2026-10-02 am EDT
|
5-day change | 1st Jan Change | ||
| 9.930 HKD | -1.39% |
|
+6.43% | +17.79% |
| Oct. 02 | Major drugmakers turn to China for licensing deals | RE |
| Oct. 01 | CSPC Reports Blood Sugar Reduction in Phase III Diabetes Study | MT |
| Market Cap | 113B 14.45B 12.84B 11.98B 10.92B 20.59B 1,389B 20.79B 145B 56.18B 710B 54.24B 53.06B 2,278B | P/E 2026 * |
11.2x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 13.02B 11.57B 10.79B 9.84B 18.56B 1,251B 18.73B 131B 50.62B 640B 48.87B 47.81B 2,053B | EV / Sales 2026 * |
2.66x | EV / Sales 2027 * | 2.78x |
| Free-Float |
67.42% | Yield 2026 * |
4.63% | Yield 2027 * | 3.71% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1093 | Delayed | |
Tradegate
| CVG | Real-time | |
|
OTC Markets
| CHJTF | Delayed | |
|
Boerse Muenchen
| CVG | Real-time | |
|
Deutsche Boerse AG
| CVG | Delayed | |
|
Börse Stuttgart
| CVG | Delayed |
| 1 day | -1.39% | ||
| 1 week | +6.43% | ||
| Current month | -1.39% | ||
| 1 month | +3.33% | ||
| 3 months | +24.12% | ||
| 6 months | +2.27% | ||
| Current year | +17.79% |
| 1 week | 9.29 |  | 10.16 |
| 1 month | 8.52 | | 10.16 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 10.96 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.87 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Cai
CEO | Chief Executive Officer | 46 | 2025-12-18 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 2025-12-18 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 2011-08-25 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 2012-01-19 |
Bo Wang
BRD | Director/Board Member | 66 | 2012-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/26 | Other | Director | -700,000 | 0.0061% | ||
| 5/29/26 | Other | Chairman | 9,402,000 | 0.0816% | ||
| 5/28/26 | Other | Chairman | 40,000,000 | 0.3471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | +6.43% | +2.37% | +84.23% | 14.45B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.82% | -2.41% | +23.70% | +61.44% | 371.16B | |
| Weighted average by Cap. | -0.60% | -3.29% | +28.97% | +71.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.47B 4.9B 4.36B 4.07B 3.71B 6.99B 471B 7.05B 49.2B 19.06B 241B 18.41B 18.01B 773B | 35.68B 4.55B 4.04B 3.77B 3.44B 6.48B 437B 6.54B 45.63B 17.68B 223B 17.07B 16.7B 717B |
| Net income | 10.14B 1.29B 1.15B 1.07B 977M 1.84B 124B 1.86B 12.97B 5.03B 63.51B 4.85B 4.75B 204B | 7.02B 894M 795M 742M 676M 1.27B 85.96B 1.29B 8.97B 3.48B 43.95B 3.36B 3.28B 141B |
| Net Debt | -11.22B -1.43B -1.27B -1.19B -1.08B -2.04B -137B -2.06B -14.35B -5.56B -70.25B -5.37B -5.25B -225B | -14.29B -1.82B -1.62B -1.51B -1.38B -2.6B -175B -2.62B -18.27B -7.08B -89.46B -6.83B -6.69B -287B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | HK$9.930 | -1.39% | 45,903,226 |
| 26-09-30 | HK$10.07 | +6.28% | 158,143,701 |
| 26-09-29 | HK$9.475 | +0.91% | 84,589,391 |
| 26-09-28 | HK$9.390 | +0.64% | 54,494,820 |
| 26-09-25 | HK$9.330 | -0.11% | 38,612,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
